Illumos Joins NVIDIA Inception

Illumos, a pioneer in next-generation pathology, has recently joined NVIDIA Inception, a program that nurtures startups revolutionizing industries with technological advancements.

Illumos is focused on advancing 3D digital pathology to help doctors and scientists better understand diseases by seeing beyond the surface. By joining NVIDIA Inception, Illumos will leverage NVIDIA’s expertise and resources to accelerate the development of its innovative pathology solutions.

“Joining NVIDIA Inception is a significant milestone for Illumos as we continue to push the boundaries of 3D pathology,” said Prof. HM Lai, CEO of Illumos. “NVIDIA’s technology and support will enable us to formulate more sophisticated 3D pathology models, speed up our image analysis pipeline, and advance our AI-driven features. The program will also offer us the opportunity to collaborate with industry-leading experts and other AI-driven organizations.”

Through the NVIDIA Inception program, Illumos will gain access to a custom set of ongoing benefits, including NVIDIA Deep Learning Institute credits, preferred pricing on NVIDIA hardware and software, and technological assistance. These resources will provide Illumos with the fundamental tools it needs to further develop and deploy its groundbreaking 3D digital pathology solutions.